Jiangxi Synergy Pharmaceutical Co., Ltd. (SZSE: 300636)
Health Care · Pharmaceuticals · CN
CN¥6.95
-1.84% today · -17.9% 1Y
Jiangxi Synergy Pharmaceutical Co., Ltd. (SZSE: 300636) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $434.17M and employs 1,623 people.
Over the last twelve months the share price has lost 17.9%, trading between 6.11 and 9.48.
Tweenvest scores Jiangxi Synergy Pharmaceutical Co., Ltd. across four factors: quality 76/100, value 48/100, growth 42/100, dividend 10/100. Its strongest factor is quality.
300636 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $434.17M
- Revenue (TTM)
- $119.78M
- P/E
- 41.07
- EPS
- 0.17
- Dividend yield
- 0.58%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥9.48
- 52-week low
- CN¥6.11
- Avg volume (3M)
- —
- Shares outstanding
- 419.95M
- Employees
- 1,623
- Next earnings
- —
About Jiangxi Synergy Pharmaceutical Co., Ltd.
Headquartered in Yichun, People's Republic of China, Jiangxi Synergy Pharmaceutical Co., Ltd. was established in 2004. The company specializes in the global production and sale of active pharmaceutical ingredients (APIs), as well as liquid crystal compounds and various chemical intermediates.
- ISIN
- CNE100002P83
- Founded
- 2004
- Listed since
- Mar 31, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,237.51 | -1.43% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.29 | +0.76% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.48 | -1.36% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.89 | -0.64% |
Figures last refreshed Aug 18, 2026.